Glaxosmithkline Pharmaceuticals Ltd.

GLAXO Share PricePharmaceuticals & Drugs

2,479.4

-15.1 (-0.6%)

As on November 14, 2025

Exchange Scrips: BSE500660NSEGLAXOISININE159A01016

Market Cap41,945 Cr

P/E Ratio 45.28

Dividend Yield 0.22 %

Performance

Market performance

Open2,499.8
High2,515.2
Volumes51,386
Prev2,479.4
Low2,470.9
As on2025-11-14

Historical performance

1 Year High3,515.7
3 Year High3,515.7
5 Year High3,515.7
1 Year Low1,921
3 Year Low1,227
5 Year Low1,227

Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
41,945
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
45.28
Dividend Yield
Dividend Yield
0.22 %

Investment Returns

1 Year
0.9%
3 Years
85.3%
5 Years
71.9%
10 Years
57.2%

Technicals

IndicatorsValueSignal
5-DMA2,499.34Bearish
10-DMA2,565Bearish
20-DMA2,637.47Bearish
50-DMA2,708.45Bearish
100-DMA2,870.74Bearish
200-DMA2,810.17Bearish

Shareholding Pattern

FieldSep-2025Jun-2025Mar-2025Dec-2024Sep-2024
Promoters44444
Foreign Investors44444
Domestic Investors---------------
Public Investors122900123625121881119621119224
Government22332

Financials

Below figures are in Rs. Crores

Balance Sheet

Below figures are in Rs. Crores

Cash Flow

Below figures are in Rs. Crores

0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 45.28.
  • 3Y Stock Price CAGR of the stock is 23.1.
  • The stock has a beta of 0.8.
  • In the last financial year, the company had an EBITDA of ₹13233 Million.
  • The company generated revenue of ₹37492 Million in the previous financial year.

Glaxosmithkline Pharmaceuticals Ltd.

2479.4-15.1   (-0.6%)

Investment Amount: ₹ 1000000
Current Value: ₹ 1028092.8
No. of Shares: 415 (Approx)
Performance:2.8%
P/L: ₹28092.8

Top Gainers

SymbolChange%
IVC9.11(19%)
GVPIL354.95(18%)
AARVI137.68(15%)
IPCALAB1479.6(14%)
KRBL429.35(13%)

Top Losers

SymbolChange%
TOLINS168.46(-10%)
FISCHER58.75(-10%)
WEALTH1051.8(-10%)
ATL31.49(-9%)
MASTERTR104.98(-8%)
THOMASCOTT418.7(-8%)
MALLCOM1270.2(-8%)
LAXMIINDIA137.12(-7%)

Peer Comparison

Medicamen Biotech Ltd.

33.3%

410.65

1 Month Performance

Venus Remedies Ltd.

26.5%

571.85

1 Month Performance

Strides Pharma Science Ltd.

18.6%

943.55

1 Month Performance

Bafna Pharmaceuticals Ltd.

18.5%

181.17

1 Month Performance

Biocon Ltd.

16.9%

411.15

1 Month Performance

Acutaas Chemicals Ltd.

14.3%

1711.1

1 Month Performance

Laurus Labs Ltd.

13.8%

999

1 Month Performance

Ipca Laboratories Ltd.

13.3%

1479.6

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month